Technical Analysis for CERT - Certara, Inc.

Grade Last Price % Change Price Change
C 27.52 3.97% 1.05
CERT closed up 0.57 percent on Wednesday, July 28, 2021, on approximately normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
Earnings due: Aug 5
*** please verify all earnings dates ***

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Up Up
Historical CERT trend table...

Date Alert Name Type % Chg
20 DMA Support Bullish 3.97%
Crossed Above 50 DMA Bullish 3.97%
Pocket Pivot Bullish Swing Setup 3.97%
Outside Day Range Expansion 3.97%
Fell Below 50 DMA Bearish 4.56%
20 DMA Support Bullish 4.56%
20 DMA Support Bullish 3.65%
50 DMA Support Bullish 3.65%
MACD Bullish Signal Line Cross Bullish 3.65%
Narrow Range Bar Range Contraction 3.65%
Older End-of-Day Signals for CERT ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 5% about 6 hours ago
60 Minute Opening Range Breakout about 6 hours ago
Up 1 ATR about 7 hours ago
Up 3% about 7 hours ago
Rose Above Previous Day's High about 7 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Certara, Inc. Description

Certara Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinincal and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software and technology to transform drug discovery and development. The company also provides related technology-enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Its technology-enabled services include mechanistic biosimulation, empirical biosimulation, drug development and regulatory strategy, clinical pharmacology, model-based meta-analysis, regulatory writing and medical communications, regulatory operations, and market access. The company serves biopharmaceutical companies and academic institutions. It has operations in the United States, Canada, Spain, Luxembourg, Portugal, the United Kingdom, Germany, France, the Netherlands, Denmark, Switzerland, Italy, Poland, Japan, the Philippines, India, and Australia. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Life Sciences Pharmaceutical Industry Health Sciences Pharmacy Medication Drug Discovery Pharmacology Drug Development Pharmaceutical Sciences Systems Biology

Is CERT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 41.79
52 Week Low 23.75
Average Volume 406,092
200-Day Moving Average 0.00
50-Day Moving Average 26.45
20-Day Moving Average 26.17
10-Day Moving Average 25.54
Average True Range 1.07
ADX 12.74
+DI 22.20
-DI 23.54
Chandelier Exit (Long, 3 ATRs) 25.56
Chandelier Exit (Short, 3 ATRs) 26.95
Upper Bollinger Bands 28.37
Lower Bollinger Band 23.97
Percent B (%b) 0.57
BandWidth 16.82
MACD Line -0.23
MACD Signal Line -0.36
MACD Histogram 0.1339
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 27.96
Resistance 3 (R3) 27.86 27.28 27.71
Resistance 2 (R2) 27.28 26.90 27.32 27.62
Resistance 1 (R1) 26.87 26.66 27.08 26.97 27.54
Pivot Point 26.29 26.29 26.39 26.33 26.29
Support 1 (S1) 25.88 25.91 26.09 25.98 25.40
Support 2 (S2) 25.30 25.67 25.34 25.32
Support 3 (S3) 24.89 25.30 25.23
Support 4 (S4) 24.99